Institutional Engagement Sample Clauses

Institutional Engagement. Annual and final reports must provide evidence of broadened engagement of institutions in RII Track-2- supported activities of the consortium. These reports must also include evidence of enhanced collaboration among the consortium’s universities and colleges, including non-research intensive institutions, and utilization of resources residing therein.
Sample 1Sample 2
AutoNDA by SimpleDocs
Institutional Engagement. Templates and text included in the annual and final reports must provide evidence of broadened engagement of jurisdiction’s institutions in RII-supported activities. These reports must also include evidence of enhanced collaboration among the jurisdiction's universities and colleges, including primarily undergraduate institutions and 2-year institutions, and utilization of resources residing therein.
Sample 1Sample 2
Institutional Engagement. Subdomains for institutional engagement include demand, satisfaction and perceived value, engagement of hospital director and staff, and educational message and awareness (Figure 21). Three out of six hospitals met the cut off for sustainability in the domain of institutional engagement. Apam had the highest average at 2.5, Kete-Kratchi scored 2.4, and Axim had a score of 2.3. Mampong hovered close to the cut off at 1.9, Bole had a score of 1.6, and Kintampo had the lowest average score of 1.3. Scores for satisfaction and perceived value were calculated from multiple scores relating to director and maintenance staff satisfaction with the system and the commitment of the director to the sustainability of the water system. Scores for educational message and awareness were also calculated from multiple scores relating to staff and patient awareness of the water system, and the presence of educational messages on water and sanitation. Subdomain scores were relatively high showing strengths in satisfaction, perceived value of the treatment system, and in engagement of hospital director and staff. All hospitals had low scores in the subdomain for visibility of educational messages in the hospital and awareness of the water treatment system. Educational messages regarding safe water were only observed in Apam hospital. Educational messages regarding hygiene practices were observed in all six hospitals. In three hospitals, educational messages about hygiene were visible to the staff, but not to the patients. Ratings of perceived value and satisfaction about the system by the hospital directors varied across all hospitals. The hospital directors reported overall satisfaction with pressure, color of water, and costs of maintaining the system, but mentioned concerns about water quality within the hospital wards, and poor capacity of maintenance staff to carryout of major system repairs. Hospital directors also had varying levels of commitment to the sustainability of the water treatment system and safe water provision.
Sample 1

Related to Institutional Engagement

  • Investigational Services This plan covers certain experimental or investigational services as described in this section. This plan covers clinical trials as required under R.I. General Law § 27-20-60. An approved clinical trial is a phase I, phase II, phase III, or phase IV clinical trial that is being performed to prevent, detect or treat cancer or a life-threatening disease or condition. In order to qualify, the clinical trial must be: • federally funded; • conducted under an investigational new drug application reviewed by the Food and Drug Administration (FDA); or • a drug trial that is exempt from having such an investigational new drug application. To qualify to participate in a clinical trial: • you must be determined to be eligible, according to the trial protocol; • a network provider must have concluded that your participation would be appropriate; and • medical and scientific information must have been provided establishing that your participation in the clinical trial would be appropriate. If a network provider is participating in a clinical trial, and the trial is being conducted in the state in which you reside, you may be required to participate in the trial through the network provider. Coverage under this plan includes routine patient costs for covered healthcare services furnished in connection with participation in a clinical trial. The amount you pay is based on the type of service you receive. Coverage for clinical trials does not include: • the investigational item, device, or service itself; • items or services provided solely to satisfy data collection and that are not used in the direct clinical management; or • a service that is clearly inconsistent with widely accepted standards of care.

  • Professional Services Bodily injury" or "property damage" arising out of the rendering of or failure to render profes- sional services;

  • COVERED HEALTHCARE SERVICES This section describes covered healthcare services. This plan covers services only if they meet all of the following requirements: • Listed as a covered healthcare service in this section. The fact that a provider has prescribed or recommended a service, or that it is the only available treatment for an illness or injury does not mean it is a covered healthcare service under this plan. • Medically necessary, consistent with our medical policies and related guidelines at the time the services are provided. • Not listed in Exclusions Section. • Received while a member is enrolled in the plan. • Consistent with applicable state or federal law. We review medical necessity in accordance with our medical policies and related guidelines. Our medical policies can be found on our website. Our medical policies are written to help administer benefits for the purpose of claims payment. They are made available to you for informational purposes and are subject to change. Medical policies are not meant to be used as a guide for your medical treatment. Your medical treatment remains a decision made by you with your physician. If you have questions about our medical policies, please call Customer Service. When a new service or drug becomes available, when possible, we will review it within six (6) months of one of the events described below to determine whether the new service or drug will be covered: • the assignment of an American Medical Association (AMA) Current Procedural Terminology (CPT) code in the annual CPT publication; • final Food and Drug Administration (FDA) approval; • the assignment of processing codes other than CPT codes or approval by governing or regulatory bodies other than the FDA; • submission to us of a claim meeting the criteria above; and • generally, the first date an FDA approved prescription drug is available in pharmacies (for prescription drug coverage only). During the review period, new services and drugs are not covered. For all covered healthcare services, please see the Summary of Medical Benefits and the Summary of Pharmacy Benefits to determine the amount that you pay and any benefit limits.

  • Professional Services Warranty Kodak warrants that it shall perform Professional Services in a professional manner using appropriately skilled personnel in accordance with generally accepted industry standards and Kodak’s then current policies and procedures. Subject to the provisions of condition 16.1 Customer’s sole and exclusive remedy under the warranty described in this condition shall be, at Kodak’s option, (1) re-performance of the non-conforming Professional Services, or (2) refund of the amount paid by Customer for the non-conforming Professional Services.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!